华康洁净 (301235)
Wuhan Huakang Century Clean Technology Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 10777.45
- Circulating A-Shares(W): 7274.28
- Earnings Per Share(RMB): 0.7700
- Net Assets Per Share(RMB): 16.8732
- Operating Revenue(W RMB): 143148.47
- Total Profit(W RMB): 7200.10
- Net Profit Attributable to Parent(W RMB): 6115.67
- Net Profit Growth Rate(%): 211.46
- Weighted Return on Equity(%): 3.3900
- Operating Cash Flow Per Share(RMB): -2.8270
- Undistributed Profit Per Share(RMB): 4.0630
- Capital Reserve Per Share(RMB): 12.0802
2. Main Business
The main business covers:
- R&D, design, implementation, and operation & maintenance of medical special projects, laboratories, and electronic cleanroom purification systems.
- Sales of related medical equipment and medical consumables.
3. Company Basic Information
- Company Name: Wuhan Huakang Century Clean Technology Co., Ltd.
- Listing Date: 2022-01-28
- Industry: Construction and Installation
- Address: Building 3, No.718 Gaoxin Avenue, East Lake High-tech Development Zone, Wuhan City, Hubei Province
- Website: www.whhksj.com
- Company Profile：The issuer was established by the overall change of Huakang Co., Ltd. into a joint stock company. According to the “Zhonghui Audit [2019] No. 4961” “Audit Report” issued by Zhonghui Certified Public Accountants (Special General Partnership), as of July 31, 2019, the audited net assets of Huakang Co., Ltd. were 410,672,144.96 yuan. According to the “Tianyuan Evaluation Report [2019] No. 0491” “Asset Appraisal Report” issued by Tianyuan Asset Appraisal Co., Ltd., as of the appraisal base date July 31, 2019, the appraised value of the net assets of Huakang Co., Ltd. was 428,751,400.00 yuan. On November 12, 2019, all promoters jointly signed the “Sponsor Agreement of Wuhan Huakang Century Medical Co., Ltd.”, agreeing to convert the audited net assets of 410,672,144.96 yuan as of July 31, 2019 into 79.20 million shares of the joint stock company at a ratio of 1:0.1929, with a par value of 1.00 yuan per share, and the balance of 331,472,144.96 yuan was included in the capital reserve. On November 28, 2019, Zhonghui Certified Public Accountants (Special General Partnership) issued the “Zhonghui Verification [2019] No. 5045” “Capital Verification Report”, which reviewed the capital contribution for the overall change of Huakang Co., Ltd. into a joint stock company, verifying that the subscribed capital contributions of all promoter shareholders had been fully paid. On the same day, the company held its founding meeting and the first shareholders' meeting, and Wuhan Huakang Century Medical Co., Ltd. was officially established. On December 18, 2019, the company completed the industrial and commercial change registration at the Wuhan Market Supervision Administration and obtained the “Business License” with the unified social credit code 91420100682300843F.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Sunshine Life Insurance Co., Ltd. - Dividend Insurance Product | Insurance | 538.84 | 7.41 |
| 2 | Wuhan Kanghui Investment Management Center (Limited Partnership) | General Legal Person | 481.54 | 6.62 |
| 3 | Fullgoal Enhanced Bond Securities Investment Fund Class A | Fund | 180.00 | 2.47 |
| 4 | Guolian Securities Asset Management - SPD Bank - Guolian Huakang Medical Employee Participation in ChiNext Strategic Placement Collective Asset Management Plan | Asset Management Plan | 61.74 | 0.85 |
| 5 | Fullgoal Fujia Absolute Return Hybrid Pension Product - Agricultural Bank of China Co., Ltd. | General Legal Person | 53.90 | 0.74 |
| 6 | Fullgoal Jiuli Steady Allocation Hybrid Securities Investment Fund Class A | Fund | 49.78 | 0.68 |
| 7 | China Merchants Quantitative Selected Stock Initiated Securities Investment Fund Class A | Fund | 47.00 | 0.65 |
| 8 | Changjiang Huizhi Quantitative Stock Selection Hybrid Initiated Securities Investment Fund Class A | Fund | 1.60 | 0.02 |
5. Concept Sectors
- Convertible Bonds
- Smart Healthcare
- Artificial Intelligence
- Chip
- Medical Waste Treatment
- Assisted Reproduction
- Margin Trading & Securities Lending
- High-Performance Stock
- Shareholder Reduction
- Below IPO Price
- Specialized and Sophisticated SMEs
- Special Loans
- CSI Repurchase Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information